Homocysteine concentrations in patients with diabetes mellitus - Relationship to microvascular and macrovascular disease

Diabetes, Obesity and Metabolism

Volumn 7, Issue 2, 2005, Pages 117-121

  Elias, Alan N ^a,b   Eng, Steven ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Homocysteine; Macrovascular disease; Microvascular disease; Renal failure

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; COLESTYRAMINE; FIBRIC ACID DERIVATIVE; HOMOCYSTEINE; INSULIN; METFORMIN; METHOTREXATE; NICOTINIC ACID; TROGLITAZONE;

AMINO ACID BLOOD LEVEL; AMINO ACID SYNTHESIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HUMAN; HYPERHOMOCYSTEINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC SYNDROME X; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; REVIEW; RISK FACTOR; VASCULAR DISEASE;

EID: 14844348743     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00376.x     Document Type: Review

References (44)

1. Baumgartner ER, Wick H, Maurer R, Egli N, Steinmann B. Congenital defect in intracellular cobalamin metabolism resulting in homocysteinuria and methylmalonic aciduria. I. Case report and histopathology. Helv Paediatr Acta 1979; 34: 465-482.
2. Kluijtmans LA, Kastelein JJ, Lindemans J et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997; 96: 2573-2577.
3. Allen RH, Stabler SP, Lindenbaum J. Relevance of vitamins, homocysteine and other metabolites in neuropsychiatric disorders. Eur J Pediatr 1998; 157 (Suppl. 2): S122-S126.
4. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency I. usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990; 34: 90-98.
5. Kruger WD. Vitamins and homocysteine metabolism. Vitam Horm 2000; 60: 333-352.
6. Gradman WS, Daniel J, Miller B, Haji-Aghaii M. Homocysteine-associated acute mesenteric artery occlusion treated with thrombectomy and bowel resection. Ann Vasc Surg 2001; 15: 247-250.
7. Fritsma G. Laboratory results that predict arterial thrombosis. Clin Lab Sci 2001; 14: 262-268.
8. Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids 2001; 36 (Suppl.): S13-S26.
9. den Heijer M, Keijzer MB. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med 2001; 39: 710-713.
10. Mudd SH. Diseases of sulphur metabolism. implications for the methionine-homocysteine cycle, and vitamin responsiveness. Ciba Found Symp 1979; 239-258.
11. Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE. Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun 1972; 46: 905-912.
12. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975; 24: 721-735.
13. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038.
14. Davies L, Wilmshurst EG, McElduff A, Gunton J, Clifton-Bligh P, Fulcher GR. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care 2001; 24: 1805-1809.
15. Hultberg B, Agardh E, Andersson A et al. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 277-282.
16. House JD, Jacobs RL, Stead LM, Brosnan ME, Brosnan JT. Regulation of homocysteine metabolism. Adv Enzyme Regul 1999; 39: 69-91.
17. Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 1998; 47: 1967-1970.
18. Emoto M, Kanda H, Shoji T et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001; 24: 533-538.
19. Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest 2002; 53: 157-162.
20. Drzewoski J, Czupryniak L, Chwatko G, Bald E. Hyperhomocysteinemia in poorly controlled type 2 diabetes patients. Diabetes Nutr Metab 2000; 13: 319-324.
21. Pavia C, Ferrer I, Valls C, Artuch R, Colome C, Vilaseca MA. Total homocysteine in patients with type 1 diabetes. Diabetes Care 2000; 23: 84-87.
22. Cotellessa M, Minniti G, Cerone R, Prigione F, Calevo MG, Lorini R. Low total plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 2001; 24: 969-971.
23. Robillon JF, Canivet B, Candito M et al. Type 1 diabetes mellitus and homocyst(e)ine. Diabetes Metab 1994; 20: 494-496.
24. Meigs JB, Jacques PF, Selhub J et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001; 24: 1403-1410.
25. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998; 139: 197-198.
26. Desouza C, Keebler M, McNamara DB, Fonseca V. Drugs affecting homocysteine metabolism: impact on cardiovascular risk. Drugs 2002; 62: 605-616.
27. Hoogeveen EK, Kostense PJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus? J Intern Med 1997; 242: 389-394.
28. Fonseca V, Keebler M, Dicker-Brown A et al. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats. Metabolism 2002; 51: 783-786.
29. Agardh E, Hultberg B, Agardh CD. Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine. Scand J Clin Lab Invest 2000; 60: 169-174.
30. Agardh CD, Agardh E, Andersson A, Hultberg B. Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 1994; 54: 637-641.
31. Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW. Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metabolism 1999; 48: 1096-1101.
32. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999; 55: 1028-1035.
33. Fonseca VA, Reynolds T, Fink LM. Hyperhomocysteinemia and microalbuminuria in diabetes. Diabetes Care 1998; 21: 1028.
34. Jager A, Kostense PJ, Nijpels G et al. Serum homocysteine levels are associated with the development of (micro) albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol 2001; 21: 74-81.
35. Ambrosch A, Dierkes J, Lobmann R et al. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabet Med 2001; 18: 185-192.
36. Cohen JA, Jeffers BW, Stabler S, Schrier RW, Estascio R. Increasing homocysteine levels and diabetic autonomic neuropathy. Auton Neurosci 2001; 87: 268-273.
37. Berwanger CS, Jeremy JY, Stansby G. Homocysteine and vascular disease. Br J Surg 1995; 82: 726-731.
38. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
39. Duell PB, Malinow MR. Homocyst (e) ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 1997; 8: 28-34.
40. Fanapour PC, Yug B, Kochar MS. Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ 1999; 98: 51-54.
41. Fortin LJ, Genest J Jr. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem 1995; 28: 155-162.
42. Lippi G, Arosio E, Prior M, Guidi G. Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens. Angiology 2001; 52: 681-687.
43. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
44. van den Berg M, Boers GH. Homocystinuria: what about mild hyperhomocysteinaemia? Postgrad Med J 1996; 72: 513-518.